BridgeBio Pharma Newsroom

Scotiabank Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Raises Target Price to $45

Futu NewsNov 16 02:31

BridgeBio Pharma Analyst Ratings

BenzingaNov 16 01:12

A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $45 to $45

Futu NewsNov 14 21:05

Analysts Are Neutral on These Healthcare Stocks: Fate Therapeutics (FATE), BridgeBio Pharma (BBIO)

TipRanksNov 13 21:14

Wells Fargo Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $58

Futu NewsNov 13 18:38

TD Cowen Maintains BridgeBio Pharma(BBIO.US) With Buy Rating

Futu NewsNov 13 05:32

TD Cowen Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

TipRanksNov 13 05:29

Mizuho Securities Maintains BridgeBio Pharma(BBIO.US) With Buy Rating

Futu NewsOct 26 00:31

Leerink Partners Maintains BridgeBio Pharma(BBIO.US) With Buy Rating

Futu NewsOct 25 23:34

Scotiabank Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $44

Futu NewsOct 25 20:33

Positive Outlook on BridgeBio Pharma's BBP-812 Gene Therapy: Buy Rating Reaffirmed

TipRanksOct 25 18:37

H.C. Wainwright Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $43

Futu NewsOct 25 18:31

BridgeBio Pharma Is Maintained at Outperform by Leerink Partners

Dow JonesOct 17 22:53

Leerink Partners Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Cuts Target Price to $46

Futu NewsOct 17 20:31

J.P. Morgan Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Announces Target Price $43

Futu NewsOct 17 19:31

BridgeBio Pharma Analyst Ratings

BenzingaOct 16 22:02

Mizuho Securities Maintains BridgeBio Pharma(BBIO.US) With Buy Rating

Futu NewsOct 16 21:35

BridgeBio Pharma Receives 'Buy' Rating Amid Positive Regulatory Outlook for Acoramidis

TipRanksOct 16 20:49

Scotiabank Initiates BridgeBio Pharma at Sector Outperform With $44 Price Target

MT NewswiresOct 16 20:24

Mizuho Securities Maintains BridgeBio Pharma(BBIO.US) With Buy Rating

Futu NewsOct 11 16:36